suck pdf from google scholar
unlimited free pdf from europmc18360641    free
PDF from PMC    free
html from PMC    free
PDF vom PMID18360641 :   free
PDF vom PMID18360641 :   free
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text

  • DeepDyve
  • Pubget Overpricing

  • lüll
  • Montelukast in the management of allergic rhinitis
  • Lagos JA; Marshall GD
  • Ther Clin Risk Manag 2007[Jun]; 3 (2): 327-32
  • Allergic rhinitis is the most common atopic disorder seen in the outpatient clinic setting diagnosed by history, physical exam and objective testing. According to the Allergic Rhinitis and its Impact on Asthma (ARIA) document, it is classified by chronicity (intermittent or persistent), and severity which is based on symptoms and quality of life (mild, or moderate/severe). It has enormous socioeconomic costs and significant reduction in quality of life. Allergen avoidance should be implemented, particularly in children, to reduce level of exposure; unfortunately efforts are often inadequate. Montelukast, a novel medication, is an antagonist to the leukotriene receptor. It is nonsedating, dosed once daily, and has a safety profile similar in adults and children with approval down to 6 months of age. A review of the literature undoubtedly establishes montelukast as a viable alternative for the treatment of seasonal allergic rhinitis. Its benefits are equivalent to antihistamines, when used as monotherapy, but less than intranasal corticosteroids. The addition of an antihistamine to montelukast does appear to have added benefits and at times is reported to be equivalent to intranasal corticosteroids.
  • ä

  • *{{pmid18360641}}
    *<b>[ Montelukast in the management of allergic rhinitis ]</b> Ther Clin Risk Manag 2007; 3(2) ; 327-32 Lagos JA; Marshall GD


    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    Ther Clin Risk Manag

    327 2.3 2007